46
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Novel Methods in Vascular and Lymphatic Physiology

      Submit here by June 30, 2025

      About Journal of Vascular Research: 1.8 Impact Factor I 3.4 CiteScore I 0.486 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Intracellular pH in the Resistance Vasculature: Regulation and Functional Implications

      review-article

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Net acid extrusion from vascular smooth muscle (VSMCs) and endothelial cells (ECs) in the wall of resistance arteries is mediated by the Na<sup>+</sup>,HCO<sub>3</sub><sup>–</sup> cotransporter NBCn1 ( SLC4A7) and the Na<sup>+</sup>/H<sup>+</sup> exchanger NHE1 ( SLC9A1) and is essential for intracellular pH (pH<sub>i</sub>) control. Experimental evidence suggests that the pH<sub>i</sub> of VSMCs and ECs modulates both vasocontractile and vasodilatory functions in resistance arteries with implications for blood pressure regulation. The connection between disturbed pH<sub>i</sub> and altered cardiovascular function has been substantiated by a genome-wide association study showing a link between NBCn1 and human hypertension. On this basis, we here review the current evidence regarding (a) molecular mechanisms involved in pH<sub>i</sub> control in VSMCs and ECs of resistance arteries at rest and during contractions, (b) implications of disturbed pH<sub>i</sub> for resistance artery function, and (c) involvement of disturbed pH<sub>i</sub> in the pathogenesis of vascular disease. The current evidence clearly implies that pH<sub>i</sub> of VSMCs and ECs modulates vascular function and suggests that disturbed pH<sub>i</sub> either consequent to disturbed regulation or due to metabolic challenges needs to be taken into consideration as a mechanistic component of artery dysfunction and disturbed blood pressure regulation.

          Related collections

          Author and article information

          Journal
          JVR
          J Vasc Res
          10.1159/issn.1018-1172
          Journal of Vascular Research
          S. Karger AG
          1018-1172
          1423-0135
          2012
          October 2012
          18 August 2012
          : 49
          : 6
          : 479-496
          Affiliations
          Department of Biomedicine and Water and Salt Research Center, Aarhus University, Aarhus, Denmark
          Author notes
          *Dr. Ebbe Boedtkjer, Department of Biomedicine, Aarhus University, Ole Worms Allé 6, Building 1180, DK–8000 Aarhus C (Denmark), Tel. +45 8716 7283, E-Mail eb@fi.au.dk
          Article
          341235 J Vasc Res 2012;49:479–496
          10.1159/000341235
          22907294
          aa0a6d45-4818-4ef7-90b1-2fe2f9e74573
          © 2012 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 17 April 2012
          : 20 June 2012
          Page count
          Figures: 7, Pages: 18
          Categories
          Review

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Nitric oxide,Endothelial cells,Vascular smooth muscle cells,Vasoconstriction,Hypertension,Vasorelaxation, SLC9A1 , SLC4A7 ,Hypoxia-reoxygenation,Resistance arteries

          Comments

          Comment on this article

          Related Documents Log